2Almeida M, Ambrogini E,Han L, et al.Oxidative stress stimulates the synthesis of PPAR gamma 2, and ligand-activated PPAR gamma 2 sequesters beta-catenin leading to suppression ofTCF-mediatedtranscription: anexpla nation for the age related decrease inosteoblastogenesis and increase in adipogenesis[J]. J Bone Miner Res. 2009, 23: S29-S29.
3DobrianAD, Schriver SD, KhraibiAA, et al. Pioglitazone prevents hypertension and reduces oxidative stress in diet-induced obesity[J]. Hypertension, 2004,43: 48- 56.
4KimHa-il, Ji YoungCha, So-YounKim, etal. Peroxisomal proliferator - activated receptor-upregulates glucokinase gene expression in cells[J]. diabetes, 2002,51: 676-685.
5Tontonoz P, HuE, Graves RA, etal. mPPARgamma2: tissue specific regulator of an adipocyte enhancer[J]. Genos Dev, 1994, 8: 1224- 1234.
6Barroso I, Gurnell M, Crowley VE, et al. Dominant negative mutations in human PPAR gamma associated with severe insulin resistance, tension [J], Nature, 1999 diabetes mellitus and hyper 402: 860- 861.
7Coll the PPAR ino M, Aragno M, Ma oxidative stress -gamma agonists in stro and the cola R, et a7. Modulation of inflammatory response by hippocampus of rats exposed to cerebral ischemia/reperfusion[J]. Eur J Pharmacol 2006, 530: 70-80.
8HwangJ, KleinhenzDJ, HeidiL, et al. ThePPARY ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice[J]. Vasc Pharmacol.2007.46: 456-462.
9Clara D, Maria M, Vania P, et al. Increased expression of transglutaminase-1 and PPARY after vitamin E trea tment in human keratinocytes[J]. Arch Biochem Biophys, 2006.447: 97- 106.
3Valve R, Sivenius K, Miettinen R, et al. Two polymorphisms in the peroxisome proliferator - activated receptor - gamma gene are associated with severe overweight among obese women. J Clin Endocrinol Metab 1999,84(10):3708.
4Freake HC. A genetic mutation in PPAR gamma is associated with enhanced fat cell differentiation: implicationsfor human obesity. Nutr Rev 1999, 57(5 Pt 1) :154.
5Kubota N, Terauchi Y, Miki H, et al. PPAR gamma mediates high - fat diet - induced adipocyte hypertrophy and insulin resistance. Mol Cell 1999, 4 (4) :597.
6Zhou YT, Wang ZW, Higa M, et al. Reversing adipocyte differentiation: implications for treaatment of obesity. Proc Natl Acad Sci USA 1999,96(5) :2391.
7Edvardsson U, Bergstrom M, Alexandersson M, et al.Rosiglitazone(BRL 49653 ), a PPARgamma- selective agonist,causes peroxisome proliferator - like liver effects in obese mice. J Lipid Res 1999,40(7) :1177.
8KEANEY J F,LARSON M G,VASAN R S,et al.Obesity and systemic oxidative stress:clinical correlates of oxidative stress in the framingham study[J].Arterioscler Thromb Vase Biol,2003,23(3):434-439.
9STRAUSS R S.Comparison of serum concentrations of alpha-tocopherol and beta-carotene in a cross-sectional sample of obese and nonobese children (NHANES III)[J].J Pediatr,1999,134(2):160-165.
10DOBRIAN A D,SCHRIVER S D,KHRAIBI A A et al.Pioglitazone prevents hypertention and reduces oxidative stress in diet-induced obesity[J].Hypertension,2004,43:48-56.
